Moreover, TLK2 depletion culminates in a BLM-dependent, STING-mediated innate immune response, whereby, in many human cancers, TLK1/2 expression correlates with signatures of chromosomal instability and anti-correlates with STING and innate and adaptive immune response signatures [45]. The gene discussed is TLK1; the disease is cancer.